Additional activation of the AR gene may be involved in the development of the castration resistance phenotype in prostate cancer (2022)
- Authors:
- USP affiliated authors: SROUGI, MIGUEL - FM ; LEITE, KATIA RAMOS MOREIRA - FM
- Unidade: FM
- DOI: 10.1016/j.acuro.2020.11.012
- Subjects: CROMOSSOMOS HUMANOS; NEOPLASIAS PROSTÁTICAS; FENÓTIPOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Actas urologicas espanolas
- ISSN: 0210-4806
- Volume/Número/Paginação/Ano: v. 46, n. 2, p. 78-84, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ROMAO, P et al. Additional activation of the AR gene may be involved in the development of the castration resistance phenotype in prostate cancer. Actas urologicas espanolas, v. 46, n. 2, p. 78-84, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.acuro.2020.11.012. Acesso em: 18 fev. 2026. -
APA
Romao, P., Souza, I. de C., Silva, I., Guimaraes, V. R., Camargo, J. A. de, Santos, G. A. dos, et al. (2022). Additional activation of the AR gene may be involved in the development of the castration resistance phenotype in prostate cancer. Actas urologicas espanolas, 46( 2), 78-84. doi:10.1016/j.acuro.2020.11.012 -
NLM
Romao P, Souza I de C, Silva I, Guimaraes VR, Camargo JA de, Santos GA dos, Viana NI, Srougi M, Leite KRM, Reis ST, Pimenta R. Additional activation of the AR gene may be involved in the development of the castration resistance phenotype in prostate cancer [Internet]. Actas urologicas espanolas. 2022 ; 46( 2): 78-84.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.acuro.2020.11.012 -
Vancouver
Romao P, Souza I de C, Silva I, Guimaraes VR, Camargo JA de, Santos GA dos, Viana NI, Srougi M, Leite KRM, Reis ST, Pimenta R. Additional activation of the AR gene may be involved in the development of the castration resistance phenotype in prostate cancer [Internet]. Actas urologicas espanolas. 2022 ; 46( 2): 78-84.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.acuro.2020.11.012 - Treating metastatic prostate cancer with microRNA-145
- PD-L1 expression in renal cell carcinoma clear cell type is related to unfavorable prognosis
- Prognostic value of TERF1 expression in prostate cancer
- Controlling RECK miR21 promotes tumor cell invasion and is related to biochemical recurrence in prostate cancer
- Upregulation of shelterin and CST genes and longer telomeres are associated with unfavorable prognostic characteristics in prostate cancer
- Histologic abnormalities in non-neoplastic renal parenchyma and the risk of chronic kidney disease following radical nephrectomy
- Shorter leukocyte telomere length is associated with severity of COVID-19 infection.
- Pan-cancer analysis reveals that CTC1-STN1-TEN1 (CST) complex may have a key position in oncology
- Digital application developed to evaluate functional results following robot-assisted radical prostatectomy* App for prostate cancer
- Micro RNA expression and prognosis in low-grade non-invasive urothelial carcinoma
Informações sobre o DOI: 10.1016/j.acuro.2020.11.012 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
